Participants should be aware of the following financial/non-financial relationships:
Joel E. Abbott, DO, FACOS: Boston Scientific (Consultant/Advisory Board, Speaker/Honoraria includes speakers bureau, symposia, and expert witness)Karl Storz (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)
Lecture Summary: Discuss any topic
Learning Objectives:
Learn which patients should undergo metabolic evaluation for kidney stone disease
Learn what tests are used in the metabolic evaluation of kidney stone disease
Learn how to manage the different common metabolic abnormalities contributing to kidney stone disease
Learn how to interpret the findings of labs related to metabolic workup for kidney stone disease
